Although our data on patients' outcome according to the IL-18 secretion level need to be extended to a larger cohort and also to a supplementary and independent group of patients, they suggest that the microenvironment plays a role in T-ALL outcome via secreted factors. This evidence concerns the gene IL18 and acute lymphoblastic leukemia.